Portage Biotech Statistics
Total Valuation
PRTG has a market cap or net worth of $4.75 million. The enterprise value is $7.02 million.
| Market Cap | 4.75M |
| Enterprise Value | 7.02M |
Important Dates
The last earnings date was Wednesday, February 28, 2024, after market close.
| Earnings Date | Feb 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PRTG has 19.78 million shares outstanding. The number of shares has increased by 22.64% in one year.
| Shares Outstanding | 19.78M |
| Shares Change (YoY) | +22.64% |
| Shares Change (QoQ) | +17.39% |
| Owned by Insiders (%) | 38.82% |
| Owned by Institutions (%) | 11.61% |
| Float | 10.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.15 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.78, with a Debt / Equity ratio of 0.24.
| Current Ratio | 2.78 |
| Quick Ratio | n/a |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8,967.89 |
Financial Efficiency
Return on equity (ROE) is -232.80% and return on invested capital (ROIC) is -160.58%.
| Return on Equity (ROE) | -232.80% |
| Return on Assets (ROA) | -171.00% |
| Return on Capital (ROIC) | -160.58% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$20.70M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -25.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.08% in the last 52 weeks. The beta is 99.75, so PRTG's price volatility has been higher than the market average.
| Beta (1Y) | 99.75 |
| 52-Week Price Change | -92.08% |
| 50-Day Moving Average | 0.49 |
| 200-Day Moving Average | 1.56 |
| Relative Strength Index (RSI) | 31.39 |
| Average Volume (30 Days) | 98,359 |
Short Selling Information
The latest short interest is 8,377, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 8,377 |
| Short Previous Month | 6,448 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.08% |
| Short Ratio (days to cover) | 0.09 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -63.59M |
| Pretax Income | -170.41M |
| Net Income | -144.91M |
| EBITDA | -170.35M |
| EBIT | -170.39M |
| Earnings Per Share (EPS) | -$8.34 |
Balance Sheet
The company has $5.34 million in cash and $7.60 million in debt, giving a net cash position of -$2.26 million or -$0.11 per share.
| Cash & Cash Equivalents | 5.34M |
| Total Debt | 7.60M |
| Net Cash | -2.26M |
| Net Cash Per Share | -$0.11 |
| Equity / Book Value | 32.00M |
| Book Value Per Share | 1.62 |
| Working Capital | 4.81M |
Cash Flow
| Operating Cash Flow | -15.86M |
| Capital Expenditures | n/a |
| Free Cash Flow | -15.86M |
| FCF Per Share | -$0.76 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PRTG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.64% |
| Shareholder Yield | -22.64% |
| Earnings Yield | -3,049.32% |
| FCF Yield | -333.68% |
Analyst Forecast
The average price target for PRTG is $11.00, which is 4,213.73% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.00 |
| Price Target Difference | 4,213.73% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 4, 2020. It was a reverse split with a ratio of 1:100.
| Last Split Date | Jun 4, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |